NitroMed, Inc.

A Lesser-Appreciated Pandemic Legacy Investors in companies like Pfizer Inc. * and Roche Holding AG have discovered that developing vaccines, drugs and diagnostics that helped resolve the pandemic

When the FDA approved two gene therapies for sickle cell disease on the same day, adjectives like “momentous” were wheeled out. While the approvals were certainly landmarks, the commercialization that

The stock market is theater, a company's public show watched daily by churning audiences of thousands, some first-time punters, some gnarly hecklers. For investors, all corporations are merely players

The oft-noted inability of life sciences VCs to raise the sums they once did is not just a threat to the sector, but also an opportunity. That’s the view of Deerfield Management, which has set its sig